Technical Analysis for BIB - ProShares Ultra Nasdaq Biotechnology
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Fell Below 20 DMA | Bearish | -1.64% | |
| Down 3 Days in a Row | Weakness | -1.64% | |
| Gapped Down | Weakness | -1.64% | |
| 20 DMA Support | Bullish | -3.43% | |
| Multiple of Ten Bearish | Other | -3.43% | |
| Gapped Down | Weakness | -3.43% | |
| MACD Bearish Signal Line Cross | Bearish | -3.61% | |
| 20 DMA Support | Bullish | -3.61% |
| Alert | Time |
|---|---|
| Fell Below Previous Day's Low | about 9 hours ago |
| Down 2 % | about 9 hours ago |
| Down 1% | about 9 hours ago |
| Fell Below Previous Day's Low | 1 day ago |
| Down 1% | 1 day ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®.
The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified.
Keywords: Exchange Traded Fund ETF Exchange Traded Funds Stock Market Index Biotechnology Leveraged ETF Ultra ETF Nasdaq 100 Industry Classification Nasdaq Biotechnology Index Nasdaq Biotech Nasdaq Biotechnology Total Return Index
Classification
Keywords: Exchange Traded Fund ETF Exchange Traded Funds Stock Market Index Biotechnology Leveraged ETF Ultra ETF Nasdaq 100 Industry Classification Nasdaq Biotechnology Index Nasdaq Biotech Nasdaq Biotechnology Total Return Index
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 62.3061 |
| 52 Week Low | 39.871 |
| Average Volume | 18,531 |
| 200-Day Moving Average | 52.93 |
| 50-Day Moving Average | 56.34 |
| 20-Day Moving Average | 58.90 |
| 10-Day Moving Average | 59.26 |
| Average True Range | 1.50 |
| RSI (14) | 45.95 |
| ADX | 12.75 |
| +DI | 31.16 |
| -DI | 32.72 |
| Chandelier Exit (Long, 3 ATRs) | 57.82 |
| Chandelier Exit (Short, 3 ATRs) | 60.47 |
| Upper Bollinger Bands | 61.35 |
| Lower Bollinger Band | 56.44 |
| Percent B (%b) | 0.14 |
| BandWidth | 8.34 |
| MACD Line | 0.57 |
| MACD Signal Line | 0.89 |
| MACD Histogram | -0.3167 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 58.94 | ||||
| Resistance 3 (R3) | 59.01 | 58.47 | 58.64 | ||
| Resistance 2 (R2) | 58.47 | 58.00 | 58.43 | 58.54 | |
| Resistance 1 (R1) | 57.79 | 57.72 | 57.52 | 57.73 | 58.43 |
| Pivot Point | 57.25 | 57.25 | 57.12 | 57.22 | 57.25 |
| Support 1 (S1) | 56.58 | 56.79 | 56.31 | 56.51 | 55.81 |
| Support 2 (S2) | 56.04 | 56.50 | 56.01 | 55.70 | |
| Support 3 (S3) | 55.37 | 56.04 | 55.60 | ||
| Support 4 (S4) | 55.30 |
